Nicholas Lydon, Director at Blueprint Medicines Corp (BPMC), sold 500 shares at $80.00 ($40K) on 2020-09-17, disclosed to the SEC on 2020-09-21.
Scheduled sale ($40k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| BPMC | SELL | 2020-07-06 | $661K | — | Filing → |
| BPMC | SELL | 2020-06-25 | $32K | — | Filing → |
| BPMC | SELL | 2020-06-23 | $2.1M | — | Filing → |